Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients

被引：64
|
作者：
Maningat, Patricia [1 ]
Breslow, Jan L. [1 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 24期
关键词：
D O I：
10.1056/NEJMp1112023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2250 / 2251
页数：2
相关论文
共 50 条
  • [41] PHARMACOLOGY OF DYSLIPIDEMIA. HOW TO IMPROVE THE CHOLESTEROL-LOWERING EFFICACY OF EZETIMIBE IN STATIN-INTOLERANT PATIENTS IN CLINICAL PRACTICE: A RETROSPECTIVE STUDY
    Cicero, A.
    Morbini, M.
    D'Addato, S.
    Fogacci, F.
    Rosticci, M.
    Borghi, C.
    ATHEROSCLEROSIS, 2016, 252 : E212 - E212
  • [42] Management of hyperlipidaemia among statin-intolerant patients after acute coronary syndrome: where dowe stand in 2020?
    Agha, Ali M.
    Ballantyne, Christie M.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 30 - 32
  • [43] CHARACTERISTICS AND OUTCOMES FOR STATIN-INTOLERANT WOMEN RECEIVING BEMPEDOIC ACID IN THE CLEAR OUTCOMES TRIAL
    Cho, Leslie
    Plutzky, Jorge
    Brennan, Danielle
    Louie, Michael
    Lei, Lei
    Robinson, Paula
    Powell, Heather
    Nicholls, Stephen J.
    Lincoff, A. Michael
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1751 - 1751
  • [44] Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial
    Nissen, Steven E.
    Dent-Acosta, Ricardo E.
    Rosenson, Robert S.
    Stroes, Erik
    Sattar, Naveed
    Preiss, David
    Mancini, John
    Ballantyne, Christie M.
    Catapano, Alberico
    Gouni-Berthold, Ioanna
    Stein, Evan A.
    Xue, Allen
    Wasserman, Scott M.
    Scott, Rob
    Thompson, Paul D.
    CLINICAL CARDIOLOGY, 2016, 39 (03) : 137 - 144
  • [45] Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease
    Marazzi, Giuseppe
    Pelliccia, Francesco
    Campolongo, Giuseppe
    Quattrino, Silvia
    Cacciotti, Luca
    Volterrani, Maurizio
    Gaudio, Carlo
    Rosano, Giuseppe
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (12): : 1798 - 1801
  • [46] Incidence of muscle symptoms in placebo arm among statin-intolerant patients: a systematic review with meta-analysis
    Louro, Rita
    Melo, Ryan
    Ruivo, Jorge
    Almeida, Ana
    Pinto, Fausto
    Caldeira, Daniel
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (11) : 887 - 894
  • [47] PCSK9 inhibitor, ezetimibe, and bempedoic acid: Evidence-based therapies for statin-intolerant patients
    Gunta, Satya Preetham
    O'Keefe, James H.
    O'Keefe, Evan L.
    Lavie, Carl J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 79 : 12 - 18
  • [48] Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
    Li Jun Qian
    Yao Gao
    Yan Mei Zhang
    Ming Chu
    Jing Yao
    Di Xu
    Scientific Reports, 7
  • [49] CHARACTERISTICS AND OUTCOMES FOR STATIN-INTOLERANT WOMEN RECEIVING BEMPEDOIC ACID IN THE CLEAR OUTCOMES TRIAL
    Cho, Leslie
    Plutzky, Jorge
    Brennan, Danielle
    Louie, Michael J.
    Lei, Lei
    Robinson, Paula
    Powell, Heather A.
    Nicholls, Stephen
    Lincoff, A. Michael
    Nissen, Steve E.
    ATHEROSCLEROSIS, 2024, 395
  • [50] Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial
    Koba, Shinji
    Inoue, Ikuo
    Cyrille, Marcoli
    Lu, Chen
    Inomata, Hyoe
    Shimauchi, Junichiro
    Kajinami, Kouji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (05) : 471 - 484
12345